Bortzomib 2 mg injection is an anticancer drug that contains the active ingredient Bortezomib. Bortzomib 2 mg injection targets the protein degradation process, which is ramped up inside cancer cells. Hence, this drug is classified as a proteosome inhibitor. Bortzomib 2 mg is a targeted therapy that does not affect the body’s normal cells to a large extent.
Multiple myeloma refers to the cancer caused by the uncontrolled cell division of the plasma cells in the bone marrow. This leads to the production of abnormal proteins, bone damage, kidney impairment, and infections. For this indication, Bortzomib 2 mg injection is the first-line treatment for newly diagnosed patients or those with recurrent disease. Bortzomib 2 mg injection controls the spread of the tumor and improves survival rates in patients.
Mantle cell lymphoma is a rare and aggressive form of non-Hodgkin lymphoma. It arises from the B-lymphocytes in the lymph nodes. Bortzomib 2 mg is typically used in patients with relapsed or recurrent MCL. In some patients, it might also be combined with alternative therapies. Bortzomib 2 mg injection helps control the disease and shrink the swollen lymph nodes.
This disorder arises due to misfolded chains being produced by abnormal plasma cells. These abnormal cells can be found in the heart, kidneys, and liver, and can impair the functioning of these organs. Bortzomib 2 mg injection targets the production of these misfolded chains and slows down the progression of the disease. As a result, the organ function is also improved.
These uses are not officially approved for treatment with Bortzomib 2 mg. However, Bortzomib 2 mg injection can be effective in the treatment of:
The dosage of Bortzomib 2 mg injection is based on the body surface area (BSA). Hence, the unit for Bortzomib 2 mg dosage is mg/m².
You can buy Bortzomib 2 mg injection from Lifesaving-meds.com at low price online with free shipping & free sample medicines. Lifesaving-meds.com provide Bortzomib 2 mg injection at very less wholesale price for sale from India with low price guarantee, big discounts, free delivery, credit card / debit card, Zellepay, paypal, crypto / Bitcoin payment option & more in the United states of America (USA) – New York, California, Texas, Florida, Ohio, Oregon, Georgia, Denver, Illinois, Oregon, Pennsylvania, Washington, Wyoming & more; United Kingdom (UK) – London, Birmingham, Wales, Manchester & more; Europe (EU) – Moscow (Russia), Paris (France), Spain & more; and Australia (AU) – Sydney, Melbourne, Brisbane & more. So, buy Bortzomib 2 mg injection tablets near you when you are prescribed with this medication or search as Bortzomib 2 mg injection for sale near me on google, bing, yahoo, duckducko, AOL & anywhere.
Bortzomib 2 mg injection (Bortezomib) is a type of anti-cancer medication that belongs to the class of proteasome-inhibiting drugs. Bortzomib 2 mg injection used in the treatment of various types of lymphoma and multiple myeloma. Bortzomib 2 mg injection targets a specific cellular system that helps break down proteins, offering an effective treatment option for rapidly proliferating cancer cells.
Cancerous cells proliferate uncontrollably and hence produce large amounts of defective proteins. Normally, cells utilize the proteasome as part of the ubiquitin-proteasome system (UPS) to degrade unneeded or misfolded proteins. This process is particularly efficient within cancer cells that produce large amounts of protein and grow rapidly. Thus, cancer cells' reliance on the proteasome system makes them susceptible to agents that disrupt the UPS.
Bortzomib 2 mg injection irreversibly inhibits the 26S proteasome, the key component involved in the degradation of proteins inside the cell. This disruption of the proteasome leads to the accumulation of large amounts of unwanted or disrupted proteins, which leads to cellular stress. The cellular stress ultimately triggers apoptosis (programmed cell death). In addition to apoptosis, Bortzomib 2 mg also inhibits other pathways that support cancer cell growth. These pathways include NF-kB activation, which supports cancer cell survival, proliferation, and resistance to apoptosis.
This drug also affects the environment, which promotes cancer growth and survival. Bortzomib 2 mg injection reduces the adhesive signals from the tumor to the bone marrow and also interferes with angiogenesis, which supports tumor blood supply in order for tumors to grow.
By targeting the protein degradation process, which is upregulated in cancer cells, Bortzomib 2 mg injection selectively kills these cells while leaving many normal cells unaffected compared to other traditional chemotherapy agents. In this way, Bortezomib 2mg injection leads to decreased tumor size, increased death of cancer cells, and improved chances of success of treatment.
--> Blood & Lymphatic Disorders
--> Nervous System Disorders
--> Gastrointestinal Disorders
--> General & Administration Site Conditions
--> Infections & Infestations
--> Cardiac Disorders
--> Vascular Disorders
--> Respiratory, Thoracic & Mediastinal Disorders
--> Renal & Urinary Disorders
--> Hepatobiliary Disorders
--> Metabolic & Nutritional Disorders
--> Musculoskeletal & Connective Tissue Disorders
--> Skin & Subcutaneous Tissue Disorders
--> Eye Disorders
--> Ear & Labyrinth Disorders
--> Psychiatric Disorders
--> Endocrine Disorders
--> Immune System Disorders
--> Reproductive System Disorders
--> Other Important Clinical Effects
Bortzomib 2 mg injection is used in the treatment of cancers like multiple myeloma and mantle cell lymphoma, and conditions like AL amyloidosis.
Bortzomib 2mg injection must not be consumed by pregnant women as it can affect the developing fetus.
Bortzomib 2 mg can be given in the form of either subcutaneous (under the skin) or intravenous injection.
The most common side effect associated with Bortzomib 2 mg injection is peripheral neuropathy (tingling or numbness in hands and feet).
The duration of Bortzomib 2 mg therapy must be decided by the medical care provider.
